Indoco Remedies said it received final approval from the USFDA for its Abbreviated New Drug Application (ANDA) for Brivaracetam Oral Solution, 10 mg/mL
The stock was in demand after the company received EIR from the USFDA for its API manufacturing facility located at Patalganga